An Observational Study of Patients With Coronavirus Disease 2019
- Conditions
- COVID-19Coronavirus
- Registration Number
- NCT04331886
- Lead Sponsor
- Target PharmaSolutions, Inc.
- Brief Summary
This is an observational study of patients with COVID-19 designed to specifically address important clinical questions that remain incompletely answered for coronavirus disease 2019.
- Detailed Description
Data from up to 5,000 adult patients in the US will be captured from eligible patients enrolled following admission to the hospital. Participants will have de-identified medical records collected from hospital admission to discharge, including but not limited to critical care monitoring, details on mechanical ventilation, laboratory data, imaging reports, medications, and all procedures. Diagnosis and patient management will follow each hospital's standard of care and no specific treatments, procedures or laboratory tests will be dictated by enrollment in TARGET-COVID-19.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 5000
- Adults (age ≥18 years) who are or have been hospitalized and diagnosed with Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) infection.
- SARS-CoV-2 confirmed diagnosis (e.g. polymerase chain reaction [PCR] or other clinically utilized test).
N/A
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time point of clinical response 12 months Natural history of COVID-19: Characteristics of COVID-19 12 months Natural history of COVID-19: Participant demographics 12 months Natural history of COVID-19: Treatment use 12 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Washington
🇺🇸Seattle, Washington, United States